Prostate Cancer

Today is a summary article of my current thinking on the management of prostate cancer. This article was inspired by the release of two large scale studies published in the last week. First, the two articles: For reference, if you’re in the medical field, they are included as links. A POPULATION-BASED STUDY OF CARDIOVASCULAR DISEASE […]

DISCLAIMER / About the Blog – Please read once if you haven’t. And please note – today, I just talk about traditional fractionation schedules or modestly hypofractionated data. Today, I’m refreshing a post from may of 2019 where I reviewed prostate cancer radiation outcome data. That post made me focus on intermediate risk disease, and […]

Note: Today is an opinion piece on options for prostate cancer. It is MUCH more opinion based than some other entries on the blog – just a note. I still think the topic is valuable and writing these helps me to organize my thinking. Today, we’ll look at options for prostate cancer and talk about […]

Less radiation dose to normal structures is a key component of cancer treatment. Today, we’ll review very briefly 1) what SpaceOAR is, 2) why at the Oklahoma Proton Center we use it for most patients, and 3) why we think it is a great match for proton therapy and prostate cancer treatment. What is SpaceOAR? […]

LAST UPDATED: August 2019 to reflect the new August 3rd Lancet randomized prostate cancer trial. Summary of Current Prostate Cancer Outcome Data for Patients Treated with Radiation: Below is a table summarizing recent trials that have been published on prostate cancer. This table simply attempts to summarize current data comparing external beam radiation (both 3D […]

TOTAL DOSE: A SIMPLE EXAMPLE SHOWING JUST HOW MUCH LESS WE TREAT WITH PROTON THERAPY. One of the more commonly treated cancers with Proton Therapy is prostate cancer. It’s use for prostate cancer has been a controversial topic for decades as people argue costs vs. benefits. In general, I think this is because men with […]